Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R)

首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R)

【24h】

Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R)

机译：促进促妇女促释放激素激动剂在恶性卵巢生殖细胞肿瘤患者中预防化疗诱导的卵巢功能亢进的可行性和功效（KGOG 3048R）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: This study assessed the effects of gonadotropin-releasing hormone agonists (GnRHa) on the prevention of chemotherapy-induced ovarian insufficiency among young patients with malignant ovarian germ cell tumour (MOGCT) receiving chemotherapy.

机译：背景：本研究评估了促胆量释放激素激动剂（GNRHA）对预防卵巢卵巢胚芽细胞肿瘤（MOGCT）接受化疗的年轻患者的预防化疗诱导的卵巢功能亢进的影响。

著录项

来源
《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2020年第2020期|共10页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Chemotherapy; Gonadotropin releasing hormone agonist; Ovarian germ cell cancer; Ovarian insufficiency;

机译：化疗;促性腺激素释放激素激动剂;卵巢生殖细胞癌;卵巢功能不全;

相似文献

外文文献
中文文献
专利

1. Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R) [J] . European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2020,第期

机译：促进促妇女促释放激素激动剂在恶性卵巢生殖细胞肿瘤患者中预防化疗诱导的卵巢功能亢进的可行性和功效（KGOG 3048R）
2. Influence of gonadotropin-releasing hormone agonist on the effect of chemotherapy upon ovarian cancer and the prevention of chemotherapy-induced ovarian damage: an experimental study with nuu athymic mice [J] . Qiong-yan LIN, Yi-feng WANG, Hui-nan WENG, 浙江大学学报（英文版）（B辑：生物医学和生物技术） . 2012,第011期

机译：促性腺激素释放激素激动剂对卵巢癌化疗效果的影响以及预防化疗引起的卵巢损害：nu / nu无胸腺小鼠的实验研究
3. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. [J] . Isabelle Demeestere, Pauline Brice, Fedro A Peccatori, Journal of Clinical Oncology . 2013,第7期

机译：促性腺激素释放激素激动剂可预防淋巴瘤患者化疗引起的卵巢衰竭：一项前瞻性随机试验的1年随访。
4. Role of gonadotropin-releasing hormone in the ovarian cells. [D] . Kang, Sung Keun. 2000

机译：促性腺激素释放激素在卵巢细胞中的作用。
5. The feasibility and efficacy of gonadotropin-releasing hormone agonists for prevention of chemotherapy induced ovarian failure in patient with gynecological malignancies [O] . Chan-Yong Park, Sun-Young Jung, Kwang-Beom Lee, 2014

机译：促性腺激素释放激素激动剂预防妇科恶性肿瘤化疗引起的卵巢衰竭的可行性和有效性
6. The feasibility and efficacy of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian insufficiency in patient with malignant ovarian germ cell tumours [O] . M.K. Kim 2019

机译：促进促促性卵巢胚胎细胞肿瘤预防化疗诱导的化疗卵巢功能作用的可行性和疗效

Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R)

摘要

著录项

相似文献

相关主题

期刊订阅